Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist

European Journal of Pharmacology

Volumn 323, Issue 1, 1997, Pages 21-26

  Mansbach, Robert S ^a   Brooks, Elizabeth N ^a   Chen, Yuhpyng L ^a  

^a PFIZER INC   (United States)

Author keywords

CP 154,526; CRF (Corticotropin releasing factor); Depression; Learned helplessness; Rat

Indexed keywords

ANTIDEPRESSANT AGENT; BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CORTICOTROPIN RELEASING FACTOR DERIVATIVE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; IMIPRAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG ACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNED HELPLESSNESS; MALE; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSION; DISEASE MODELS, ANIMAL; HELPLESSNESS, LEARNED; IMIPRAMINE; INJECTIONS, INTRAPERITONEAL; MALE; PYRIMIDINES; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE;

EID: 0030964813     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00025-3     Document Type: Article

References (35)

1. Anisman, H. and R.M. Zacharko, 1982, Depression: the predisposing influence of stress, Behav. Brain Sci. 5, 89.
2. Arato, M., C.M. Banki and C.B. Nemeroff, 1986, Hypothalamic-pituitary-adrenal axis and suicide, Ann. NY Acad. Sci. 487, 263.
3. Blier, P., C. De Montingny and Y. Chaput, 1987, Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression, J. Clin. Psychopharmacol. 7, 24S.
4. Brady, L.S., 1994, Stress, antidepressant drugs, and the locus coeruleus, Brain Res. Bull. 35, 545.
5. Brady, L.S., H.J. Whitfield, R.J. Fox, P.W. Gold and M. Herkenham, 1991, Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain, J. Clin. Invest. 87, 831.
6. Brady, L.S., P. Gold, M. Herkenham, A. Lynn and H.J. Whitfield, 1992, The antidepressants fluoxetine, idazoxan, and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications, Brain Res. 572, 117.
7. Chappell, P.B., M.A. Smith, C.D. Kilts, G. Bissette, J. Ritchie, C. Anderson and C.B. Nemeroff, 1986, Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress, J. Neurosci. 6, 2908.
8. Davis, M., 1992, The role of the amygdala in fear-potentiated startle: implications for animal models of anxiety, Trends Pharmacol. Sci. 13, 35.
9. Dunn, A.J. and C.W. Berridge, 1990, Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?, Brain Res. Rev. 15, 71.
10. Friedman, G., 1991, Treatment of the irritable bowel syndrome, Gastroenterol. Clin. North Am. 20, 325.
11. Henn, F.A., J. Johnson, E. Edwards and D. Anderson, 1985, Melancholia in rodents: neurobiology and pharmacology, Psychopharmacol. Bull. 21, 443.
12. Holsboer, F., U.V. Bardeleben, A. Gerken, G.K. Stalla and O.A. Muller, 1984, Blunted cortiocotropin and normal cortisol response to human corticotropin-releasing factor in depression, New Engl. J. Med. 311, 1127.
13. Jimenez-Rivera, C.A., O. Segarra, G. Santacana, T. Hoffman, D.D. Savage and G.K. Weiss, 1995, Chronic imipramine treatment induces downregulation of α-2 receptors in rat's locus coeruleus and A2 region of the tractus solitarius, Life Sci. 58, 287.
14. Koob, G.F., S.C. Heinrichs, E.M. Pich, F. Menzaghi, H. Baldwin, K. Miczek and K.T. Britton, 1993, The role of corticotropin-releasing factor in behavioral responses to stress, Ciba Found. Symp. 172, 277.
15. Leshner, A.I., H. Remler, A. Biegon and D. Samuel, 1979, Desmethylimipramine (DMI) counteracts learned helplessness in rats, Psychopharmacology 66, 207.
16. Lopez, J.F., D.M. Vazquez, H. Akil and S.J. Watson, 1994, Effect of imipramine administration and swim stress on the hypothalamic pituitary adrenal axis, Endocrine 2, 723.
17. Maier, S.F. and M.E.P. Seligman, 1976, Learned helplessness: theory and evidence, J. Exp. Psychol. (Gen) 1, 3.
18. Monnikes, H., B.G. Schmidt and Y. Tache, 1993, Psychological stress-induced accelerated colonic transit in rats involves hypothalamic corticotropin-releasing factor, Gastroenterology 104, 716.
19. Nemeroff, C.B., E. Widerlov, G. Bissette, H. Walleus, I. Karlsson, K. Eklund, C.D. Kilts, P.T. Loosen and W. Vale, 1984, Elevated concentration of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients, Science 226, 1342.
20. Nemeroff, C.B., G. Bissette, H. Akil and M. Fink, 1991, Cerebrospinal fluid neuropeptides in depressed patients treated with ECT: corticotropin-releasing factor, B-endorphin and somatostatin, Br. J. Psychiatry 158, 59.
21. Owens, M.J. and C.B. Nemeroff, 1991, Physiology and pharmacology of corticotropin releasing factor, Pharmacol. Rev. 43, 425.
22. Petty, P. and A.D. Sherman, 1979, Reversal of learned helplessness by imipramine, Commun. Psychopharmacol. 3, 371.
23. Petty, P., Y.-L. Chae, G. Kramer, S. Jordan and L. Wilson, 1994, Learned helplessness sensitizes hippocampal norepinephrine to mild stress, Biol. Psychiatry 35, 903.
24. Riva, M.A. and I. Creese, 1989, Reevaluation of the regulation of β-adrenergic receptor binding by desipramine treatment, Mol. Pharmacol. 36, 211.
25. Roffler-Tarlov, S., J. Schildkraut and P. Draskoczy, 1973, Effects of acute and chronic administration of desmethylimipramine on the content of norepinephrine and other monoamines in the rat brain, Biochem. Pharmacol. 22, 2923.
26. Schulz, D.W., R.S. Mansbach, J. Sprouse, J.P. Braselton, J. Collins, M. Corman, A. Dunaiskis, S. Faraci, A.W. Schmidt, T. Seeger, F.D. Tingley, E. Winston, Y.L. Chen and J. Heym, 1996, CP-154,526, a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors, Proc. Natl. Acad. Sci. USA 93, 10477.
27. Sherman, A.D., J.L. Sacquitne and F. Petty, 1982, Specificity of the learned helplessness model of depression, Pharmacol. Biochem. Behav. 16, 449.
28. Southwick, S.M., J.H. Krystal, D.R. Johnson and D.S. Charney, 1992, Neurobiology of posttraumatic stress disorder, in: Annual Review of Psychiatry, Vol. 12, eds. A. Tasman and M.B. Riba (APA Press, Washington, DC) p. 347.
29. Swanson, L.W., P.E. Sawchenko, J. Rivier and W. Vale, 1983, Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in rat brain: an immunohistochemical study, Neuroendocrinology 36, 165.
30. Tanda, G., R. Frau and G. Dichiara, 1996, Chronic desipramine and fluoxetine differentially affect extracellular dopamine in the rat pre-frontal cortex, Psychopharmacology 127, 83.
31. Telner, J.I., R.L. Singhal and Y.D. Lapierre, 1981, Reversal of learned helplessness by nortriptyline, Prog. Neuro-Psychopharmacol. 5, 587.
32. Valentino, R.J. and R.G. Wehby, 1988, Corticotropin-releasing factor: evidence for a neurotransmitter role in the locus coeruleus during hemodynamic stress, Neuroendocrinology 48, 674.
33. Valentino, R.J., S.L. Foote and G. Aston-Jones, 1983, Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus, Brain Res. 270, 363.
34. Valentino, R.J., S.L. Foote and M.E. Page, 1993, The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses, Ann. NY Acad. Sci. 697, 173.
35. Wilner, P., 1984, The validity of animal models of depression, Psychopharmacology 83, 1.